Sivik Global Healthcare LLC Insulet Corp Transaction History

Sivik Global Healthcare LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$161.02 - $206.98 $805,100 - $1.03 Million	-5,000 Reduced 16.67%	25,000 $5.05 Million
Q1 2024 Apr 30, 2024	BUY	$163.6 - $209.11 $572,600 - $731,885	3,500 Added 13.21%	30,000 $5.14 Million
Q4 2023 Feb 05, 2024	BUY	$127.77 - $221.42 $830,505 - $1.44 Million	6,500 Added 32.5%	26,500 $5.75 Million
Q3 2023 Nov 06, 2023	BUY	$154.67 - $290.89 $3.09 Million - $5.82 Million	20,000 New	20,000 $3.19 Million
Q1 2018 May 08, 2018	SELL	$68.49 - $87.2 $3.42 Million - $4.36 Million	-50,000 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$55.67 - $71.8 $2.78 Million - $3.59 Million	50,000	50,000 $3.45 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $17.8B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.